Biotechnology
Moderna: What Do the Charts Suggest?
Let's see how things develop.
Aldeyra Therapeutics Is a Speculative Stock Worth a Small Position
Seasoned traders who understand risk could nibble on the long side of ALDX.
We're Adjusting Our Strategy for Neurocrine Biosciences
The shares have taken off and we have new price targets.
3 Small-Cap Stocks That Hold Plenty of Promise Heading Into 2023
Two of the three members of this trio already have announced positive news developments that have given their shares big lifts.
2 New Oncology Focused Small-Cap Biotechs to Keep an Eye On
Once M&A activity picks up, I could see the biotech sector easily rallying 20% or more.
Harmony Biosciences Could Soon Sing an Uplifting Tune
Here's our trading strategy for the shares.
Bristol-Myers Squibb Is Trending to the Downside
Let's take a look at the charts and indicators.
My Chart Intel Says to Shy Away From Intellia Therapeutics
The technical signals of the genome editing company are largely bearish and indicate its stock is poised to weaken.
Is It Time to Bet on Biotech?
The government is turning on the flow of money to biotech at a time when the Fed is reducing the flow of money to the economy.